Int J Thyroidol.  2024 May;17(1):53-60. 10.11106/ijt.2024.17.1.53.

Korean Thyroid Association Guidelines on the Management of Differentiated Thyroid Cancers; Part I. Initial Management of Differentiated Thyroid Cancers - Chapter 3. Perioperative Assessment of Surgical Complications 2024

• Ryu CH
• Kang HC
• Koo BS
• Kim SW
• Na DG
• Park YJ
• Park JO
• Song YS
• Woo SH
• Won HR
• Lee S
• Lee EK
• Lim DJ
• Jeon YK
• Chung YJ
• Lim JY
• Hong AR
• Korean Thyroid Association Guideline Committee on the Managements of Thyroid Nodule and Cancer

• KMID: 2556505
• DOI: http://doi.org/10.11106/ijt.2024.17.1.53

Abstract

Thyroid surgery complications include voice change, vocal fold paralysis, and hypoparathyroidism. The voice status should be evaluated pre- and post-surgery. In patients with voice change, laryngeal visualization is needed.Intraoperative neuromonitoring helps reduce recurrent laryngeal nerve injury. The measurement of serum calcium, parathyroid hormone, and 25-hydroxyvitamin D levels is recommended to evaluate perioperative parathyroid function and prescribe supplementation preoperatively if necessary. For postoperative hypoparathyroidism, vitamin D and oral calcium supplementation are indicated based on serum parathyroid hormone and calcium levels and the severity of symptoms or signs of hypocalcemia. If long-term treatment is required, the appropriateness of treatment should be evaluated based on the disease itself and the consideration of potential benefits and harms from long-term replacement.

Keyword

Thyroid cancer; Postoperative complications; Thyroidectomy; Hypoparathyroidism; Vocal fold paralysis; Hypocalcemia; Guideline; Korean Thyroid Association

Reference

References

1. Orloff LA, Wiseman SM, Bernet VJ, Fahey TJ 3rd, Shaha AR, Shindo ML, et al. 2018; American Thyroid Association statement on postoperative hypoparathyroidism: diagnosis, prevention, and management in adults. Thyroid. 28(7):830–41. DOI: 10.1089/thy.2017.0309. PMID: 29848235.

2. Chandrasekhar SS, Randolph GW, Seidman MD, Rosenfeld RM, Angelos P, Barkmeier-Kraemer J, et al. 2013; Clinical practice guideline: improving voice outcomes after thyroid surgery. Otolaryngol Head Neck Surg. 148(6 Suppl):S1–37. DOI: 10.1177/0194599813487301. PMID: 23733893.

3. Farrag TY, Samlan RA, Lin FR, Tufano RP. 2006; The utility of evaluating true vocal fold motion before thyroid surgery. Laryngoscope. 116(2):235–8. DOI: 10.1097/01.mlg.0000191472.02720.1f. PMID: 16467711.

4. Randolph GW, Kamani D. 2006; The importance of preoperative laryngoscopy in patients undergoing thyroidectomy: voice, vocal cord function, and the preoperative detection of invasive thyroid malignancy. Surgery. 139(3):357–62. DOI: 10.1016/j.surg.2005.08.009. PMID: 16546500.

5. Nam IC, Bae JS, Shim MR, Hwang YS, Kim MS, Sun DI. 2012; The importance of preoperative laryngeal examination before thyroidectomy and the usefulness of a voice questionnaire in screening. World J Surg. 36(2):303–9. DOI: 10.1007/s00268-011-1347-5. PMID: 22083436.

6. Sinclair CF, Bumpous JM, Haugen BR, Chala A, Meltzer D, Miller BS, et al. 2016; Laryngeal examination in thyroid and parathyroid surgery: an American Head and Neck Society consensus statement: AHNS consensus statement. Head Neck. 38(6):811–9. DOI: 10.1002/hed.24409. PMID: 26970554.

7. Perros P, Boelaert K, Colley S, Evans C, Evans RM, Gerrard Ba G, et al. 2014; Guidelines for the management of thyroid cancer. Clin Endocrinol (Oxf). 81 Suppl 1:1–122. DOI: 10.1111/cen.12515. PMID: 24989897.

8. Dralle H, Musholt TJ, Schabram J, Steinmuller T, Frilling A, Simon D, et al. 2013; German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors. Langenbecks Arch Surg. 398(3):347–75. DOI: 10.1007/s00423-013-1057-6. PMID: 23456424.

9. Randolph GW, Dralle H, Abdullah H, Barczynski M, Bellantone R, et al. International Intraoperative Monitoring Study Group. 2011; Electrophysiologic recurrent laryngeal nerve monitoring during thyroid and parathyroid surgery: international standards guideline statement. Laryngoscope. 121 Suppl 1:S1–16. DOI: 10.1002/lary.21119.

10. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2016; 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 26(1):1–133. DOI: 10.1089/thy.2015.0020. PMID: 26462967. PMCID: PMC4739132.

11. Maher DI, Goare S, Forrest E, Grodski S, Serpell JW, Lee JC. 2019; Routine preoperative laryngoscopy for thyroid surgery is not necessary without risk factors. Thyroid. 29(11):1646–52. DOI: 10.1089/thy.2019.0145. PMID: 31333068.

12. Haddad RI, Bischoff L, Ball D, Bernet V, Blomain E, Busaidy NL, et al. 2022; Thyroid carcinoma, version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 20(8):925–51. DOI: 10.6004/jnccn.2022.0040. PMID: 35948029.

13. Ryu CH, Lee SJ, Cho JG, Choi IJ, Choi YS, et al. Korean Society of Laryngology, Phoniatrics and Logopedics Guideline Task Force. 2022; Care and management of voice change in thyroid surgery: Korean Society of Laryngology, Phoniatrics and Logopedics clinical practice guideline. Clin Exp Otorhinolaryngol. 15(1):24–48. DOI: 10.21053/ceo.2021.00633. PMID: 34098629. PMCID: PMC8901944.

14. Dralle H, Sekulla C, Haerting J, Timmermann W, Neumann HJ, Kruse E, et al. 2004; Risk factors of paralysis and functional outcome after recurrent laryngeal nerve monitoring in thyroid surgery. Surgery. 136(6):1310–22. DOI: 10.1016/j.surg.2004.07.018. PMID: 15657592.

15. Cirocchi R, Arezzo A, D'Andrea V, Abraha I, Popivanov GI, Avenia N, et al. 2019; Intraoperative neuromonitoring versus visual nerve identification for prevention of recurrent laryngeal nerve injury in adults undergoing thyroid surgery. Cochrane Database Syst Rev. 1(1):CD012483. DOI: 10.1002/14651858.CD012483.pub2. PMID: 30659577.

16. Wong KP, Mak KL, Wong CK, Lang BH. 2017; Systematic review and meta-analysis on intra-operative neuro-monitoring in high-risk thyroidectomy. Int J Surg. 38:21–30. DOI: 10.1016/j.ijsu.2016.12.039. PMID: 28034775.

17. de Pedro Netto I, Fae A, Vartanian JG, Barros AP, Correia LM, Toledo RN, et al. 2006; Voice and vocal self-assessment after thyroidectomy. Head Neck. 28(12):1106–14. DOI: 10.1002/hed.20480. PMID: 16933312.

18. Chun BJ, Bae JS, Chae BJ, Hwang YS, Shim MR, Sun DI. 2012; Early postoperative vocal function evaluation after thyroidectomy using thyroidectomy related voice questionnaire. World J Surg. 36(10):2503–8. DOI: 10.1007/s00268-012-1667-0. PMID: 22678166.

19. Park JO, Bae JS, Chae BJ, Kim CS, Nam IC, Chun BJ, et al. 2013; How can we screen voice problems effectively in patients undergoing thyroid surgery? Thyroid. 23(11):1437–44. DOI: 10.1089/thy.2013.0262. PMID: 23829579.

20. Dionigi G, Boni L, Rovera F, Rausei S, Castelnuovo P, Dionigi R. 2010; Postoperative laryngoscopy in thyroid surgery: proper timing to detect recurrent laryngeal nerve injury. Langenbecks Arch Surg. 395(4):327–31. DOI: 10.1007/s00423-009-0581-x. PMID: 20013128.

21. Bures C, Bobak-Wieser R, Koppitsch C, Klatte T, Zielinski V, Freissmuth M, et al. 2014; Late-onset palsy of the recurrent laryngeal nerve after thyroid surgery. Br J Surg. 101(12):1556–9. DOI: 10.1002/bjs.9648. PMID: 25223396.

22. Edafe O, Antakia R, Laskar N, Uttley L, Balasubramanian SP. 2014; Systematic review and meta-analysis of predictors of post- thyroidectomy hypocalcaemia. Br J Surg. 101(4):307–20. DOI: 10.1002/bjs.9384. PMID: 24402815.

23. Seo ST, Chang JW, Jin J, Lim YC, Rha KS, Koo BS. 2015; Transient and permanent hypocalcemia after total thyroidectomy: early predictive factors and long-term follow-up results. Surgery. 158(6):1492–9. DOI: 10.1016/j.surg.2015.04.041. PMID: 26144879.

24. Vaitsi KD, Anagnostis P, Veneti S, Papavramidis TS, Goulis DG. 2021; Preoperative vitamin D deficiency is a risk factor for postthyroidectomy hypoparathyroidism: a systematic review and meta-analysis of observational studies. J Clin Endocrinol Metab. 106(4):1209–24. DOI: 10.1210/clinem/dgab039. PMID: 33484571.

25. Liu RH, Razavi CR, Chang HY, Tufano RP, Eisele DW, Gourin CG, et al. 2020; Association of hypocalcemia and magnesium disorders with thyroidectomy in commercially insured patients. JAMA Otolaryngol Head Neck Surg. 146(3):237–46. DOI: 10.1001/jamaoto.2019.4193. PMID: 31917427. PMCID: PMC6990795.

26. McLeod IK, Arciero C, Noordzij JP, Stojadinovic A, Peoples G, Melder PC, et al. 2006; The use of rapid parathyroid hormone assay in predicting postoperative hypocalcemia after total or completion thyroidectomy. Thyroid. 16(3):259–65. DOI: 10.1089/thy.2006.16.259. PMID: 16571088.

27. Asari R, Passler C, Kaczirek K, Scheuba C, Niederle B. 2008; Hypoparathyroidism after total thyroidectomy: a prospective study. Arch Surg. 143(2):132–7. discussion 8DOI: 10.1001/archsurg.2007.55. PMID: 18283137.

28. Khan AA, Bilezikian JP, Brandi ML, Clarke BL, Gittoes NJ, Pasieka JL, et al. 2022; Evaluation and management of hypoparathyroidism summary statement and guidelines from the second international workshop. J Bone Miner Res. 37(12):2568–85. DOI: 10.1002/jbmr.4691. PMID: 36054621.

29. Pasieka JL, Wentworth K, Yeo CT, Cremers S, Dempster D, Fukumoto S, et al. 2022; Etiology and pathophysiology of hypoparathyroidism: a narrative review. J Bone Miner Res. 37(12):2586–601. DOI: 10.1002/jbmr.4714. PMID: 36153665. PMCID: PMC10364481.

30. Yao L, Li J, Li M, Lin C, Hui X, Tamilselvan D, et al. 2022; Parathyroid hormone therapy for managing chronic hypoparathyroidism: a systematic review and meta-analysis. J Bone Miner Res. 37(12):2654–62. DOI: 10.1002/jbmr.4676. PMID: 36385517.

31. Bollerslev J, Rejnmark L, Marcocci C, Shoback DM, Sitges-Serra A, van Biesen W, et al. 2015; European Society of Endocrinology clinical guideline: treatment of chronic hypoparathyroidism in adults. Eur J Endocrinol. 173(2):G1–20. DOI: 10.1530/EJE-15-0628. PMID: 26160136.

32. Clarke BL. 2022; Hypoparathyroidism: update of guidelines from the 2022 International Task Force. Arch Endocrinol Metab. 66(5):604–10. DOI: 10.20945/2359-3997000000549. PMID: 36382749. PMCID: PMC10118814.

33. Bilezikian JP. 2020; Hypoparathyroidism. J Clin Endocrinol Metab. 105(6):1722–36. DOI: 10.1210/clinem/dgaa113. PMID: 32322899. PMCID: PMC7176479.

34. Clarke BL, Brown EM, Collins MT, Juppner H, Lakatos P, Levine MA, et al. 2016; Epidemiology and diagnosis of hypoparathyroidism. J Clin Endocrinol Metab. 101(6):2284–99. DOI: 10.1210/jc.2015-3908. PMID: 26943720. PMCID: PMC5393595.

35. Clarke BL. 2018; Epidemiology and complications of hypoparathyroidism. Endocrinol Metab Clin North Am. 47(4):771–82. DOI: 10.1016/j.ecl.2018.07.004. PMID: 30390812.

36. Vadiveloo T, Donnan PT, Leese CJ, Abraham KJ, Leese GP. 2019; Increased mortality and morbidity in patients with chronic hypoparathyroidism: a population-based study. Clin Endocrinol (Oxf). 90(2):285–92. DOI: 10.1111/cen.13895. PMID: 30375660.

37. Ahn SH, Lee YJ, Hong S, Park JW, Jeon YJ, Yoo BN, et al. 2023; Risk of fractures in thyroid cancer patients with postoperative hypoparathyroidism: a nationwide cohort study in Korea. J Bone Miner Res. 38(9):1268–77. DOI: 10.1002/jbmr.4871. PMID: 37338940.